Lindsay Hammons

Lindsay Hammons serves as a Clinical Assistant Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine, with clinical practice at Fred Hutchinson Cancer Center. Her academic journey includes an M.D. from Medical College of Wisconsin, residency at Icahn School of Medicine at Mount Sinai Beth Israel, and fellowship in Hematology/Oncology at Medical College of Wisconsin, where she is also board-certified in Medical Oncology and Internal Medicine.

Her research spans thrombosis outcomes, particularly pulmonary embolism response team activations, and hematologic malignancies with focus on multiple myeloma immunotherapies. Recent publications demonstrate expertise in CAR-T complications, bispecific antibody kinetics, and risk-adapted lymphoma treatment. Her work bridges clinical hematology with translational research in high-risk patient management.

Her 9 most recent publications (2019-2023) reveal concentrated work in hematologic malignancies (67%), thrombosis/pulmonary embolism (22%), and surgical complications (11%). Key trends include developing protocols for high-risk patient continuity of care and advancing immunotherapeutic approaches for refractory cancers.

Dr. Hammons maintains active clinical practice managing blood disorders including iron deficiency anemia, neutropenia, thrombosis, hemostasis issues, and sickle cell disease. Her hospital affiliations include Fred Hutchinson Cancer Center - South Lake Union where she provides specialized hematology/oncology care.